Avitas Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Avitas Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,174	Closed	-$332K	–	187
2019 Q4	$332K	Buy	3,174 +449	+16%	+$50.3K	0.09%	156
2019 Q3	$313K	Buy	2,725 +13	+0.5%	+$1.97K	0.09%	158
2019 Q2	$468K	Sell	2,712 -75	-3%	-$13K	0.13%	148
2019 Q1	$470K	Buy	+2,787	New	+$415K	0.14%	141

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Avitas Wealth Management's GWPH Position: Q1 2020 in Review

Avitas Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 3,174 shares — an estimated $332K sold.

Avitas Wealth Management first reported a position in GWPH in Q1 2019 and held it in 4 quarters. The position peaked at $470K in Q1 2019. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Avitas Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Avitas Wealth Management sold 3,174 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $332K.
Avitas Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 4 quarters.
Avitas Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $470K in Q1 2019.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Avitas Wealth Management's 13F filing for Q1 2020, filed 13 May 2020.